Literature DB >> 22730013

Relative functions of Gαs and its extra-large variant XLαs in the endocrine system.

M Bastepe1.   

Abstract

Gαs is a ubiquitous signaling protein necessary for the actions of many neurotransmitters, hormones, and autocrine/paracrine factors. Loss-of-function mutations within the gene encoding Gαs, GNAS, are responsible for multiple human diseases, including Albright's Hereditary Osteodystrophy, progressive osseous heteroplasia, and pseudohypoparathyroidism. Gain-of-function mutations in the same gene are found in various endocrine and nonendocrine tumors and in patients with McCune-Albright Syndrome and fibrous dysplasia of bone. In addition to Gαs, GNAS gives rise to multiple additional coding and noncoding transcripts. Among those, XLαs is a paternally expressed product that is partially identical to Gαs. This article reviews the cellular actions of Gαs and XLαs, focusing on the significance of XLαs relative to Gαs in mammalian physiology and human disease. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22730013     DOI: 10.1055/s-0032-1316331

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  9 in total

1.  Somitic disruption of GNAS in chick embryos mimics progressive osseous heteroplasia.

Authors:  Dana M Cairns; Robert J Pignolo; Tomoya Uchimura; Tracy A Brennan; Carter M Lindborg; Meiqi Xu; Frederick S Kaplan; Eileen M Shore; Li Zeng
Journal:  J Clin Invest       Date:  2013-07-25       Impact factor: 14.808

Review 2.  A severe inactivating PTH/PTHrP signaling disorder type 2 in a patient carrying a novel large deletion of the GNAS gene: a case report and review of the literature.

Authors:  Alessandro Brancatella; Giovanna Mantovani; Francesca M Elli; Simona Borsari; Claudio Marcocci; Filomena Cetani
Journal:  Endocrine       Date:  2020-01-14       Impact factor: 3.633

3.  Cyclic AMP, protein kinase A, and phosphodiesterases: proceedings of an international workshop.

Authors:  C A Stratakis
Journal:  Horm Metab Res       Date:  2012-09-05       Impact factor: 2.936

Review 4.  The role of genomic imprinting in biology and disease: an expanding view.

Authors:  Jo Peters
Journal:  Nat Rev Genet       Date:  2014-06-24       Impact factor: 53.242

5.  Gene Dosage Effects at the Imprinted Gnas Cluster.

Authors:  Simon T Ball; Michelle L Kelly; Joan E Robson; Martin D Turner; Jackie Harrison; Lynn Jones; Diane Napper; Colin V Beechey; Tertius Hough; Antonius Plagge; Bruce M Cattanach; Roger D Cox; Jo Peters
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

Review 6.  GNAS mutations in Pseudohypoparathyroidism type 1a and related disorders.

Authors:  Manuel C Lemos; Rajesh V Thakker
Journal:  Hum Mutat       Date:  2014-11-28       Impact factor: 4.878

7.  Transcription driven somatic DNA methylation within the imprinted Gnas cluster.

Authors:  Stuti Mehta; Christine M Williamson; Simon Ball; Charlotte Tibbit; Colin Beechey; Martin Fray; Jo Peters
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

Review 8.  Progressive osseous heteroplasia: diagnosis, treatment, and prognosis.

Authors:  Robert J Pignolo; Girish Ramaswamy; John T Fong; Eileen M Shore; Frederick S Kaplan
Journal:  Appl Clin Genet       Date:  2015-01-30

Review 9.  New Perspectives on Genomic Imprinting, an Essential and Multifaceted Mode of Epigenetic Control in the Developing and Adult Brain.

Authors:  Julio D Perez; Nimrod D Rubinstein; Catherine Dulac
Journal:  Annu Rev Neurosci       Date:  2016-04-25       Impact factor: 12.449

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.